Redesign Health builds and scales new healthcare companies from the ground up. It ideates based on identified health needs, recruits top founders, and creates startups that focus on patient solutions and provider support. The process involves in-house research, due diligence, and leveraging a network of over 200 healthcare incumbents to identify opportunities, then launching and rapidly growing these ventures until they become profitable. Revenue comes from the services provided by the portfolio companies, with potential exits through acquisitions or public offerings. Unlike firms that only invest in existing businesses, Redesign Health creates new companies designed to address significant health challenges. Their goal is to improve human health by delivering scalable, market-ready healthcare solutions and sustaining growth for the ventures they build.
Work here?Claim your company
Industries
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$492.4M
Headquarters
New York City, New York
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$492.4M
Above
Industry Average
Funded Over
4 Rounds
Parkview Health Announces Agreement to Acquire Ovation Healthcare | Redesign Health and ARC Global Merge. October 30, 2026 Check out today's featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A. Parkview Health Announces Agreement to Acquire Ovation Healthcare to Strengthen Community Healthcare Nationwide, Advance Local Affordability Parkview Health has signed an agreement to acquire Ovation Healthcare, a leading provider of shared services that strengthen the operational and financial performance of hospitals, health systems, and physician practices nationwide. As the largest rural healthcare provider in Indiana, Parkview understands the severe resource constraints facing rural hospitals nationwide. By investing in Ovation Healthcare, Parkview is bringing its administrative and operational expertise, such as in revenue cycle management and information services, to a premier national rural health platform to help providers keep care close to home in the communities that need it most. "With Ovation Healthcare, we are extending Parkview's proven operational depth across the nation to help rural providers remain independent, while continuing to drive down administrative costs for our local patients," said Rick Henvey, CEO at Parkview Health. "Rural healthcare is in crisis across the country because of a lack of resources and models that allow providers to succeed. Through Ovation, we can help rural providers lower the cost of care with essential infrastructure and allow them to focus their resources on patient care." Parkview began expanding its operational capabilities to support independent healthcare providers in 2025. Through its investment in Ovation, Parkview can expand its commitment to a national shared services platform that allows hospitals to focus their resources on clinical care while also lowering costs. Following closing, the two companies will combine their complementary operations and operate under the Ovation Healthcare brand... Full release here, originally announced October 16th, 2026. Redesign Health and ARC Global Merge to Help Health Systems Shape the Future of Healthcare From Within Redesign Health and Sheba Medical Center's ARC Global Also to Acquire AVIA, With the Three Organizations Bringing Together More Than 100 Health Systems and the Technology, Talent, and Capital to Turn Frontline Ideas Into Products and Companies that Scale Worldwide Dr. Stephen Klasko Named Chairman of the Board; Prof. Eyal Zimlichman, Founder and President of ARC Global, Joins Redesign Health as Vice Chairman Redesign Health, a global venture and applied technology firm focused on building next-generation healthcare companies, and ARC Global, the healthcare transformation engine founded at Sheba Medical Center, today announced they are merging. Together, the organizations will equip health systems to turn the ideas and experience of their own clinicians and operators into technology products, viable companies, and lasting capabilities that can improve care worldwide, with the institutions sharing in the value they create. The combined business is being launched in partnership with world-leading health systems across five continents. The organizations bring together the resources to carry innovation from an idea on the hospital floor through development, deployment, and commercialization. ARC Global's clinician-led innovation model and global network will be matched by Redesign Health's AI products, embedded engineering and company-building capabilities. Health systems will gain a path to address their own clinical and operational challenges, demonstrate what works in practice and bring successful solutions to peer institutions across a global network. Overstretched health systems globally are facing an increasingly urgent need to expand access and improve care while managing workforce constraints, rising costs and limited resources for change. While AI creates potential to tackle some of the growing pressures, implementing it in a way that's effective, safe and sustainable requires proper infrastructure, including clinical and technological expertise, engineering, institutional support and a way to scale what works beyond a pilot. The combined business is built to close that gap, placing the engineering, AI expertise and capital to deploy at scale inside the institutions that need it. Dr. Stephen Klasko, former CEO of Jefferson Health, who grew the system from a regional player into a nearly $10 billion academic medical enterprise, will serve as chairman of the board... Full release here, originally announced October 22nd, 2026.
EIN.: 831815961 | State of Incorp.: DE | Fiscal Year End: 1231Type: D | Act: 33 | File No.: 021-392910 | Film No.: 21757797
Redesign Health and Sheba’s ARC Global merge and acquire AVIA, creating a global clinician-led innovation engine connecting over 100 health systems worldwide.
Sheba sells ARC innovation arm to Redesign Health. The deal transfers management of ARC's global network and the rights to establish new hospital innovation centers to the U.S. healthcare venture builder, while Sheba retains its stakes in portfolio companies. 15:03, 22.10.26 Sheba Medical Center is selling its innovation arm, ARC, to U.S. healthcare venture builder Redesign Health in a deal valued at tens of millions of dollars. The transaction will transfer ARC's expertise in establishing and managing hospital innovation centers to the combined entity, while ARC will continue operating the innovation center at Sheba and those it runs at other medical centers worldwide. It will also retain its stakes in portfolio companies. Under the agreement, management of ARC's global network and the rights to establish additional innovation centers within hospitals will pass to the combined entity. Proceeds from the transaction will go to Sheba, with the state receiving approximately 10% of the total under existing agreements governing intellectual property transactions. The deal is intended to combine Sheba's clinical, technological and research capabilities, along with ARC's experience in developing and implementing healthcare innovation, with Redesign Health's expertise in building companies, raising investment and expanding into international markets. Established at Sheba in 2019, ARC was founded on the premise that some of the most significant advances in healthcare can emerge from within the medical system itself. Its model brings together physicians, medical staff, hospital administrators, entrepreneurs, technology companies and investors to identify challenges in healthcare and develop solutions. ARC currently supports more than 130 startups, including three unicorns, one of which is Aidoc, known for using artificial intelligence to analyze medical imaging. Its portfolio is valued at approximately $6.7 billion, and its companies have raised more than $1.5 billion in capital and recorded eight exits. Among the most notable are the $330 million sale of Belkin Vision, which developed a laser-based treatment for glaucoma, and the $300 million sale of Innovalve, which developed a heart valve that can be implanted using minimally invasive techniques. Companies in ARC's portfolio employ approximately 4,300 people. In recent years, ARC has expanded beyond Sheba to build an international network spanning 12 countries, 31 health systems and more than 300 hospitals. As part of the transaction, Prof. Eyal Zimlichman, president of ARC Global, will become vice chair of Redesign Health. Dr. Stephen Klasko, the former CEO of Jefferson Health, will serve as chair of the board of the combined entity. Founded in New York in 2018, Redesign Health builds healthcare companies and develops technology solutions for medical systems. Its model combines investment with engineering and product development, artificial intelligence expertise and support for building and scaling businesses. It has also developed a partnership with Cedars-Sinai, the prominent Los Angeles-based medical center. The deal comes as healthcare systems worldwide face mounting pressure from workforce shortages, rising costs and the need to integrate new technologies, including artificial intelligence, more quickly. Despite substantial investment and growing expectations for AI, many healthcare technologies struggle to move beyond pilot projects and achieve widespread adoption or a measurable impact on hospital operations. The combined model aims to address that gap by starting with problems identified inside healthcare systems, in collaboration with clinicians, administrators and technologists. Solutions are then developed around hospitals' needs, turned into companies with viable business models, supported through investment and implementation, and expanded to other healthcare systems once their value has been demonstrated.
/PRNewswire/ -- Redesign Health, a global venture and applied technology firm focused on building next-generation healthcare companies, and ARC Global, the...
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
201-500
Company Stage
Late Stage VC
Total Funding
$492.4M
Headquarters
New York City, New York
Founded
2018
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs